Cargando…

Quantification of the virus-host interaction in human T lymphotropic virus I infection

BACKGROUND: HTLV-I causes the disabling inflammatory disease HAM/TSP: there is no vaccine, no satisfactory treatment and no means of assessing the risk of disease or prognosis in infected people. Like many immunopathological diseases with a viral etiology the outcome of infection is thought to depen...

Descripción completa

Detalles Bibliográficos
Autores principales: Asquith, Becca, Mosley, Angelina J, Heaps, Adrian, Tanaka, Yuetsu, Taylor, Graham P, McLean, Angela R, Bangham, Charles RM
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1327681/
https://www.ncbi.nlm.nih.gov/pubmed/16336683
http://dx.doi.org/10.1186/1742-4690-2-75
_version_ 1782126514957975552
author Asquith, Becca
Mosley, Angelina J
Heaps, Adrian
Tanaka, Yuetsu
Taylor, Graham P
McLean, Angela R
Bangham, Charles RM
author_facet Asquith, Becca
Mosley, Angelina J
Heaps, Adrian
Tanaka, Yuetsu
Taylor, Graham P
McLean, Angela R
Bangham, Charles RM
author_sort Asquith, Becca
collection PubMed
description BACKGROUND: HTLV-I causes the disabling inflammatory disease HAM/TSP: there is no vaccine, no satisfactory treatment and no means of assessing the risk of disease or prognosis in infected people. Like many immunopathological diseases with a viral etiology the outcome of infection is thought to depend on the virus-host immunology interaction. However the dynamic virus-host interaction is complex and current models of HAM/TSP pathogenesis are conflicting. The CD8+ cell response is thought to be a determinant of both HTLV-I proviral load and disease status but its effects can obscure other factors. RESULTS: We show here that in the absence of CD8+ cells, CD4+ lymphocytes from HAM/TSP patients expressed HTLV-I protein significantly more readily than lymphocytes from asymptomatic carriers of similar proviral load (P = 0.017). A high rate of viral protein expression was significantly associated with a large increase in the prevalence of HAM/TSP (P = 0.031, 89% of cases correctly classified). Additionally, a high rate of Tax expression and a low CD8+ cell efficiency were independently significantly associated with a high proviral load (P = 0.005, P = 0.003 respectively). CONCLUSION: These results disentangle the complex relationship between immune surveillance, proviral load, inflammatory disease and viral protein expression and indicate that increased protein expression may play an important role in HAM/TSP pathogenesis. This has important implications for therapy since it suggests that interventions should aim to reduce Tax expression rather than proviral load per se.
format Text
id pubmed-1327681
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-13276812006-01-14 Quantification of the virus-host interaction in human T lymphotropic virus I infection Asquith, Becca Mosley, Angelina J Heaps, Adrian Tanaka, Yuetsu Taylor, Graham P McLean, Angela R Bangham, Charles RM Retrovirology Research BACKGROUND: HTLV-I causes the disabling inflammatory disease HAM/TSP: there is no vaccine, no satisfactory treatment and no means of assessing the risk of disease or prognosis in infected people. Like many immunopathological diseases with a viral etiology the outcome of infection is thought to depend on the virus-host immunology interaction. However the dynamic virus-host interaction is complex and current models of HAM/TSP pathogenesis are conflicting. The CD8+ cell response is thought to be a determinant of both HTLV-I proviral load and disease status but its effects can obscure other factors. RESULTS: We show here that in the absence of CD8+ cells, CD4+ lymphocytes from HAM/TSP patients expressed HTLV-I protein significantly more readily than lymphocytes from asymptomatic carriers of similar proviral load (P = 0.017). A high rate of viral protein expression was significantly associated with a large increase in the prevalence of HAM/TSP (P = 0.031, 89% of cases correctly classified). Additionally, a high rate of Tax expression and a low CD8+ cell efficiency were independently significantly associated with a high proviral load (P = 0.005, P = 0.003 respectively). CONCLUSION: These results disentangle the complex relationship between immune surveillance, proviral load, inflammatory disease and viral protein expression and indicate that increased protein expression may play an important role in HAM/TSP pathogenesis. This has important implications for therapy since it suggests that interventions should aim to reduce Tax expression rather than proviral load per se. BioMed Central 2005-12-09 /pmc/articles/PMC1327681/ /pubmed/16336683 http://dx.doi.org/10.1186/1742-4690-2-75 Text en Copyright © 2005 Asquith et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Asquith, Becca
Mosley, Angelina J
Heaps, Adrian
Tanaka, Yuetsu
Taylor, Graham P
McLean, Angela R
Bangham, Charles RM
Quantification of the virus-host interaction in human T lymphotropic virus I infection
title Quantification of the virus-host interaction in human T lymphotropic virus I infection
title_full Quantification of the virus-host interaction in human T lymphotropic virus I infection
title_fullStr Quantification of the virus-host interaction in human T lymphotropic virus I infection
title_full_unstemmed Quantification of the virus-host interaction in human T lymphotropic virus I infection
title_short Quantification of the virus-host interaction in human T lymphotropic virus I infection
title_sort quantification of the virus-host interaction in human t lymphotropic virus i infection
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1327681/
https://www.ncbi.nlm.nih.gov/pubmed/16336683
http://dx.doi.org/10.1186/1742-4690-2-75
work_keys_str_mv AT asquithbecca quantificationofthevirushostinteractioninhumantlymphotropicvirusiinfection
AT mosleyangelinaj quantificationofthevirushostinteractioninhumantlymphotropicvirusiinfection
AT heapsadrian quantificationofthevirushostinteractioninhumantlymphotropicvirusiinfection
AT tanakayuetsu quantificationofthevirushostinteractioninhumantlymphotropicvirusiinfection
AT taylorgrahamp quantificationofthevirushostinteractioninhumantlymphotropicvirusiinfection
AT mcleanangelar quantificationofthevirushostinteractioninhumantlymphotropicvirusiinfection
AT banghamcharlesrm quantificationofthevirushostinteractioninhumantlymphotropicvirusiinfection